Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.13
+0.01 (0.11%)
At close: Jun 6, 2025, 4:00 PM
9.58
+0.45 (4.93%)
After-hours: Jun 6, 2025, 5:36 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M